Both Switzerland and the United Kingdom are known for being industry leaders in all aspects related to Cell and Gene Therapy. It is for this reason that our Swiss delegation to the University of Cambridge aims to promote the exchange of best practices and key learnings from their respective ecosystems.
Novartis has recently announced its intent to invest up to 90 million Swiss francs to build a production facility for innovative cell and gene therapies in Stein in the canton of Aargau. What does this mean for Switzerland's research landscape? And how can the United Kingdom profit from this? We are bringing the UK- and Swiss-based ecosystems together for a joint discussion on current key topics with regards to R&D, business opportunities and future ambitions. Join us for an afternoon filled with exciting presentations and networking opportunities in one of the world's most prestigious Universities.
Intro
信息
| 日期 | |
| 目标受众 | Swiss Exporters, Associations, Clusters, Decision / Policy Makers, Swiss and UK-based Government, Innovation Communities (Startups & intermediaries), Academics, Industry Experts |
| 组织者 | Swiss Business Hub UK + Ireland, Switzerland Global Enterprise |
| 活动语言 |
English |
| Place |
Cambridge Building |
| 报名费 | CHF 670 (Gold Members), CHF 750 (Silver Members), CHF 790 (Non-Members) |
Program
Package
Included in the costs are:
- Full organization of the program and coordination of local speakers / activities
- Invitation and coordination of relevant stakeholders for networking
- Local transportation
- Catering
- Networking
- Full participation in the program
Not included:
- Flight booking and travel costs to/from Cambridge
- Accommodation
